Need help finding what you are looking for?
Contact Us
PUBLISHER: Grand View Research | PRODUCT CODE: 1869961
PUBLISHER: Grand View Research | PRODUCT CODE: 1869961
Middle East mRNA Synthesis Raw Material Market Size, Share & Trends Analysis Report By Type (Capping Agents, Nucleotides, Plasmid DNA), By Application, By End Use, By Country, And Segment Forecasts, 2025 - 2033
PUBLISHED:
PAGES: 150 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Market Size & Trends:
The Middle East mRNA synthesis raw material market size was valued at USD 51.8 million in 2024 and is expected to reach USD 77.3 million by 2033, expanding at a CAGR of 4.73% from 2025 to 2033. The market is driven by the increasing acceptance of mRNA-based therapeutics and vaccines, the expansion of biopharmaceutical manufacturing capacity, and the growing investment in genomic and molecular research in the region.
Rising adoption of mRNA-based vaccines And therapeutics
One of the main factors driving the growth of the mRNA synthesis raw material market is the increasing demand for mRNA-based vaccines and therapeutics. The historic performance of mRNA vaccines during the COVID-19 pandemic has confirmed the technological effectiveness documented in initial R&D efforts and the scalability and flexibility of mRNA "as a platform" to redefine modern medicine. This positive momentum in R&D activity generated demand for raw materials to prepare high-quality mRNA-associated products, with increased need for raw materials, such as nucleotides, capping reagents, enzymes, and lipid excipients, for mRNA synthesis and formulation.
Moreover, the increasing pipeline of mRNA therapeutics moving into clinical trials promotes long-term market growth. Governments and international health organizations are also supporting mRNA vaccine development programs to improve pandemic preparedness and fulfill other unmet medical needs. The expanding use of mRNA technologies for personalized and precision medicine, primarily in cancer immunotherapy, continues to generate ongoing demand for tailored, GMP-grade synthesis materials. Collectively, the common clinical acceptance of mRNA and diversification of its uses is becoming more evident as an important market component of next-generation therapeutic innovation.
Middle East mRNA Synthesis Raw Material Market Report Segmentation
This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For the purpose of this report, Grand View Research has segmented the Middle east mRNA synthesis raw material market on the basis of type, application, end-use, and country.
- Type Outlook (Revenue, USD Million, 2021 - 2033)
- Capping Agents
- CleanCap Reagents
- ARCA (Anti-Reverse Cap Analog)
- Others
- Nucleotides
- Modified Nucleic Acids
- N1-methylpseudouridine-triphosphate
- 5-Methylcytidine triphosphate (5mCTP)
- Natural Nucleic Acids
- Adenine
- Guanine
- Cytosine
- Uracil
- Plasmid DNA
- Enzymes
- Polymerase
- RNase Inhibitor
- DNase
- Others
- Others
- Application Outlook (Revenue, USD Million, 2021 - 2033)
- Vaccine Production
- Therapeutics Production
- Others
- End Use Outlook (Revenue, USD Million, 2021 - 2033)
- Biopharmaceutical & Pharmaceutical Companies
- CROs & CMOs
- Academic & Research Institutes
- Country Outlook (Revenue, USD Million, 2021 - 2033)
- Saudi Arabia
- UAE
- Kuwait
- Qatar
- Oman
- Rest of Middle East
Product Code: GVR-4-68040-788-4
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Market Definitions
- 1.2.1. Type Segment
- 1.2.2. Application Segment
- 1.2.3. End Use Segment
- 1.3. Information analysis
- 1.4. Market formulation & data visualization
- 1.5. Data validation & publishing
- 1.6. Information Procurement
- 1.6.1. Primary Research
- 1.7. Information or Data Analysis
- 1.8. Market Formulation & Validation
- 1.9. Market Model
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Snapshot
- 2.3. Competitive Insights Landscape
Chapter 3. Middle East mRNA Synthesis Raw Materials Market Variables & Trends
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook.
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Advancements in mRNA technology
- 3.2.1.2. Rising adoption of mRNA-based vaccines and therapeutics
- 3.2.2. Market restraint analysis
- 3.2.1. Market driver analysis
- 3.3. Middle East mRNA Synthesis Raw Materials Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.2. PESTEL Analysis
Chapter 4. Middle East mRNA Synthesis Raw Materials Market: Type Estimates & Trend Analysis
- 4.1. Type Segment Dashboard
- 4.2. Middle East mRNA Synthesis Raw Materials Market Type Movement Analysis
- 4.3. Middle East mRNA Synthesis Raw Materials Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
- 4.4. Capping Agents
- 4.4.1. Capping agents market estimates and forecasts 2021 to 2033 (USD Million)
- 4.4.2. CleanCap Reagents
- 4.4.2.1. CleanCap reagents market estimates and forecasts 2021 to 2033 (USD Million)
- 4.4.3. ARCA (Anti-Reverse Cap Analog)
- 4.4.3.1. ARCA (Anti-Reverse Cap Analog) market estimates and forecasts 2021 to 2033 (USD Million)
- 4.4.4. Others
- 4.4.4.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
- 4.5. Nucleotides
- 4.5.1. Nucleotides market estimates and forecasts 2021 to 2033 (USD Million)
- 4.5.2. Modified nucleic acids
- 4.5.2.1. Modified nucleic acids market estimates and forecasts 2021 to 2033 (USD Million)
- 4.5.2.2. N1-methylpseudouridine-triphosphate
- 4.5.2.2.1. N1-methylpseudouridine-triphosphate market estimates and forecasts 2021 to 2033 (USD Million)
- 4.5.2.3. 5-Methylcytidine triphosphate (5mCTP)
- 4.5.2.3.1. 5-Methylcytidine triphosphate (5mCTP) market estimates and forecasts 2021 to 2033 (USD Million)
- 4.5.2.4. Others
- 4.5.2.4.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
- 4.5.3. Natural nucleic acids
- 4.5.3.1. Natural nucleic acids market estimates and forecasts 2021 to 2033 (USD Million)
- 4.5.3.2. Adenine
- 4.5.3.2.1. Adenine market estimates and forecasts 2021 to 2033 (USD Million)
- 4.5.3.3. Guanine
- 4.5.3.3.1. Guanine market estimates and forecasts 2021 to 2033 (USD Million)
- 4.5.3.4. Cytosine
- 4.5.3.4.1. Cytosine market estimates and forecasts 2021 to 2033 (USD Million)
- 4.5.3.5. Uracil
- 4.5.3.5.1. Uracil market estimates and forecasts 2021 to 2033 (USD Million)
- 4.6. Plasmid DNA
- 4.6.1. Plasmid DNA market estimates and forecasts 2021 to 2033 (USD Million)
- 4.7. Enzymes
- 4.7.1. Enzymes market estimates and forecasts 2021 to 2033 (USD Million)
- 4.7.2. Polymerase
- 4.7.2.1. Polymerase market estimates and forecasts 2021 to 2033 (USD Million)
- 4.7.3. RNase Inhibitor
- 4.7.3.1. RNase inhibitor market estimates and forecasts 2021 to 2033 (USD Million)
- 4.7.4. DNase
- 4.7.4.1. DNase market estimates and forecasts 2021 to 2033 (USD Million)
- 4.8. Others
- 4.8.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 5. Middle East mRNA Synthesis Raw Materials Market: Application Estimates & Trend Analysis
- 5.1. Application Segment Dashboard
- 5.2. Middle East mRNA Synthesis Raw Materials Market Application Movement Analysis
- 5.3. Middle East mRNA Synthesis Raw Materials Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
- 5.4. Vaccine Production
- 5.4.1. Vaccine production market estimates and forecasts 2021 to 2033 (USD Million)
- 5.5. Therapeutics Production
- 5.5.1. Therapeutics production market estimates and forecasts 2021 to 2033 (USD Million)
- 5.6. Others
- 5.6.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 6. Middle East mRNA Synthesis Raw Materials Market: End Use Estimates & Trend Analysis
- 6.1. End Use Segment Dashboard
- 6.2. Middle East mRNA Synthesis Raw Materials Market End Use Movement Analysis
- 6.3. Middle East mRNA Synthesis Raw Materials Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
- 6.4. Biopharmaceutical & Pharmaceutical Companies
- 6.4.1. Biopharmaceutical & pharmaceutical companies market estimates and forecasts 2021 to 2033 (USD Million)
- 6.5. CROs & CMOs
- 6.5.1. CROs & CMOs market estimates and forecasts 2021 to 2033 (USD Million)
- 6.6. Academic & Research Institutes
- 6.6.1. Academic & research institutes market estimates and forecasts 2021 to 2033 (USD Million)
Chapter 7. Middle East mRNA Synthesis Raw Material Market: Regional Estimates & Trend Analysis
- 7.1. Country Market Share Analysis, 2023 & 2033
- 7.2. Country Market Dashboard
- 7.3. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
- 7.4. Middle East
- 7.4.1. Saudi Arabia
- 7.4.1.1. Key country dynamics
- 7.4.1.2. Competitive scenario
- 7.4.1.3. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
- 7.4.2. UAE
- 7.4.2.1. Key country dynamics
- 7.4.2.2. Competitive scenario
- 7.4.2.3. UAE market estimates and forecasts 2021 to 2033 (USD Million)
- 7.4.3. Kuwait
- 7.4.3.1. Key country dynamics
- 7.4.3.2. Competitive scenario
- 7.4.3.3. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)
- 7.4.4. Qatar
- 7.4.4.1. Key country dynamics
- 7.4.4.2. Competitive scenario
- 7.4.4.3. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)
- 7.4.5. Oman
- 7.4.5.1. Key country dynamics
- 7.4.5.2. Competitive scenario
- 7.4.5.3. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)
- 7.4.6. Rest of Middle East
- 7.4.6.1. Key country dynamics
- 7.4.6.2. Competitive scenario
- 7.4.6.3. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)
- 7.4.1. Saudi Arabia
Chapter 8. Competitive Landscape
- 8.1. Company/Competition Categorization
- 8.2. Strategy Mapping
- 8.3. Company Market Position Analysis, 2024
- 8.4. Company Profiles/Listing
- 8.4.1. F. Hoffmann-La Roche Ltd.
- 8.4.1.1. Company overview
- 8.4.1.2. Financial performance
- 8.4.1.3. Service benchmarking
- 8.4.1.4. Strategic initiatives
- 8.4.2. Jena Bioscience GmbH
- 8.4.2.1. Company overview
- 8.4.2.2. Financial performance
- 8.4.2.3. Service benchmarking
- 8.4.2.4. Strategic initiatives
- 8.4.3. Merck KGaA
- 8.4.3.1. Company overview
- 8.4.3.2. Financial performance
- 8.4.3.3. Service benchmarking
- 8.4.3.4. Strategic initiatives
- 8.4.4. Yeasen Biotechnology (Shanghai) Co., Ltd.
- 8.4.4.1. Company overview
- 8.4.4.2. Financial performance
- 8.4.4.3. Service benchmarking
- 8.4.4.4. Strategic initiatives
- 8.4.5. BOC Sciences
- 8.4.5.1. Company overview
- 8.4.5.2. Financial performance
- 8.4.5.3. Service benchmarking
- 8.4.5.4. Strategic initiatives
- 8.4.6. Thermo Fisher Scientific, Inc.
- 8.4.6.1. Company overview
- 8.4.6.2. Financial performance
- 8.4.6.3. Service benchmarking
- 8.4.6.4. Strategic initiatives
- 8.4.7. Maravai LifeSciences
- 8.4.7.1. Company overview
- 8.4.7.2. Financial performance
- 8.4.7.3. Service benchmarking
- 8.4.7.4. Strategic initiatives
- 8.4.8. New England Biolabs
- 8.4.8.1. Company overview
- 8.4.8.2. Financial performance
- 8.4.8.3. Service benchmarking
- 8.4.8.4. Strategic initiatives
- 8.4.9. Creative Biogene
- 8.4.9.1. Company overview
- 8.4.9.2. Financial performance
- 8.4.9.3. Service benchmarking
- 8.4.9.4. Strategic initiatives
- 8.4.10. HONGENE
- 8.4.10.1. Company overview
- 8.4.10.2. Financial performance
- 8.4.10.3. Service benchmarking
- 8.4.10.4. Strategic initiatives
- 8.4.1. F. Hoffmann-La Roche Ltd.
Product Code: GVR-4-68040-788-4
List of Tables
- Table 1 List of abbreviation
- Table 2 Middle East mRNA synthesis raw material market, by country, 2021 - 2033 (USD Million)
- Table 3 Middle East mRNA synthesis raw material market, by type, 2021 - 2033 (USD Million)
- Table 4 Middle East mRNA synthesis raw material market, by application, 2021 - 2033 (USD Million)
- Table 5 Middle East mRNA synthesis raw material market, by end-use, 2021 - 2033 (USD Million)
- Table 6 UAE Middle East mRNA synthesis raw materials market, by type, 2021 - 2033 (USD Million)
- Table 7 UAE Middle East mRNA synthesis raw materials market, by application, 2021 - 2033 (USD Million)
- Table 8 UAE Middle East mRNA synthesis raw materials market, by end-use, 2021 - 2033 (USD Million)
- Table 9 Kuwait Middle East mRNA synthesis raw materials market, by type, 2021 - 2033 (USD Million)
- Table 10 Kuwait Middle East mRNA synthesis raw materials market, by application, 2021 - 2033 (USD Million)
- Table 11 Kuwait Middle East mRNA synthesis raw materials market, by end-use, 2021 - 2033 (USD Million)
- Table 12 Qatar Middle East mRNA synthesis raw materials market, by type, 2021 - 2033 (USD Million)
- Table 13 Qatar Middle East mRNA synthesis raw materials market, by application, 2021 - 2033 (USD Million)
- Table 14 Qatar Middle East mRNA synthesis raw materials market, by end-use, 2021 - 2033 (USD Million)
- Table 15 Oman Middle East mRNA synthesis raw materials market, by type, 2021 - 2033 (USD Million)
- Table 16 Oman Middle East mRNA synthesis raw materials market, by application, 2021 - 2033 (USD Million)
- Table 17 Oman Middle East mRNA synthesis raw materials market, by end-use, 2021 - 2033 (USD Million)
- Table 18 Rest of Middle East mRNA synthesis raw material market, by type, 2021 - 2033 (USD Million)
- Table 19 Rest of Middle East mRNA synthesis raw material market, by application, 2021 - 2033 (USD Million)
- Table 20 Rest of Middle East mRNA synthesis raw material market, by end-use, 2021 - 2033 (USD Million)
List of Figures
- Fig. 1 Middle East mRNA synthesis raw materials market segmentation
- Fig. 2 Information procurement
- Fig. 3 Data analysis models
- Fig. 4 Market formulation and validation
- Fig. 5 Data validating & publishing
- Fig. 6 Market research process
- Fig. 7 Information procurement
- Fig. 8 Primary research
- Fig. 9 Market snapshot
- Fig. 10 Segment snapshot
- Fig. 11 Competitive landscape snapshot
- Fig. 12 Middle East mRNA synthesis raw materials market: Type outlook key takeaways
- Fig. 13 Middle East mRNA synthesis raw materials market: Type movement analysis
- Fig. 14 Capping agents market, 2021 - 2033 (USD Million)
- Fig. 15 CleanCap Reagents market, 2021 - 2033 (USD Million)
- Fig. 16 ARCA (Anti-Reverse Cap Analog) market, 2021 - 2033 (USD Million)
- Fig. 17 Others market, 2021 - 2033 (USD Million)
- Fig. 18 Nucleotides market, 2021 - 2033 (USD Million)
- Fig. 19 Modified Nucleic Acids market, 2021 - 2033 (USD Million)
- Fig. 20 N1-methylpseudouridine-triphosphate market, 2021 - 2033 (USD Million)
- Fig. 21 5-Methylcytidine triphosphate (5mCTP) market, 2021 - 2033 (USD Million)
- Fig. 22 Others market, 2021 - 2033 (USD Million)
- Fig. 23 Natural Nucleic Acids market, 2021 - 2033 (USD Million)
- Fig. 24 Adenine market, 2021 - 2033 (USD Million)
- Fig. 25 Guanine market, 2021 - 2033 (USD Million)
- Fig. 26 Cytosine market, 2021 - 2033 (USD Million)
- Fig. 27 Uracil market, 2021 - 2033 (USD Million)
- Fig. 28 Plasmid DNA market, 2021 - 2033 (USD Million)
- Fig. 29 Enzymes market, 2021 - 2033 (USD Million)
- Fig. 30 Polymerase market, 2021 - 2033 (USD Million)
- Fig. 31 RNase Inhibitor market, 2021 - 2033 (USD Million)
- Fig. 32 DNase market, 2021 - 2033 (USD Million)
- Fig. 33 Others market, 2021 - 2033 (USD Million)
- Fig. 34 Others market, 2021 - 2033 (USD Million)
- Fig. 35 Middle East mRNA synthesis raw materials market: Application outlook and key takeaways
- Fig. 36 Middle East mRNA synthesis raw materials market: Application movement analysis
- Fig. 37 Therapeutics production market, 2021 - 2033 (USD Million)
- Fig. 38 Vaccine production market, 2021 - 2033 (USD Million)
- Fig. 39 Other applications market, 2021 - 2033 (USD Million)
- Fig. 40 Middle East mRNA synthesis raw materials market: End-user outlook and key takeaways
- Fig. 41 Middle East mRNA synthesis raw materials market: End-user movement analysis
- Fig. 42 Biopharmaceutical & pharmaceutical companies market, 2021 - 2033 (USD Million)
- Fig. 43 CROs & CMOs market, 2021 - 2033 (USD Million)
- Fig. 44 Academic & research institutes market, 2021 - 2033 (USD Million)
- Fig. 45 Country marketplace outlook, 2023 & 2033 (USD Million)
- Fig. 46 Country marketplace: Key takeaways
- Fig. 47 Key country dynamics
- Fig. 48 Saudi Arabia Middle East mRNA synthesis raw materials market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 49 Key country dynamics
- Fig. 50 UAE Middle East mRNA synthesis raw materials market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 51 Key country dynamics
- Fig. 52 Kuwait Middle East mRNA synthesis raw materials market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 53 Key country dynamics
- Fig. 54 Qatar Middle East mRNA synthesis raw materials market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 55 Key country dynamics
- Fig. 56 Oman Middle East mRNA synthesis raw materials market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 57 Key country dynamics
- Fig. 58 Rest of Middle East mRNA synthesis raw material market estimates and forecasts, 2021 - 2033 (USD Million)
- Fig. 59 Market participant categorization
- Fig. 60 Strategic framework
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.